Vorasidenib in IDH-Mutant Glioma | NEJM
407
0
2023-12-21 17:46
Brain tumor surgery Lung cancer with metastasis to the brain Frontal craniotomy
Awake mini-pterional craniotomy GBM (glioblastoma) and minimally invasive keyhole principles.
Awake Brain Surgery - Video presentation of brain tumor resection.
Surgical resection of a metastatic lung cancer to brain. Brain tumor surgery.
Meningioma Surgery - Brain Surgery and Removal of a Large Brain Tumor Near Motor Cortex
Brain surgery - Temporal craniotomy for resection of brain tumor (meningioma) with bony invasion.
Left frontal metastatic brain tumor - Surgical resection using sodium fluorescein microscopy
Parietal craniotomy for resection of metastatic brain tumor.
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
Gliomas are the most common malignant primary brain tumor in adults, and most grade 2 gliomas have mutations in isocitrate dehydrogenase 1 and 2, the inhibitory targets of the drug vorasidenib.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3N8N5dU
Comments 0
Please to post a comment~
Loading...
Related Suggestion